Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative

D. Husain, J. W. Miller, A. G. Kenney, N. Michaud, Thomas J Flotte, E. S. Gragoudas

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Purpose: To study the efficacy of liposomal benzoporphyrin derivative (BPD) (Verteporfin) for the angiographic visualization and photodynamic therapy (PDT) of experimental iris neovascularization. Methods: Experimental iris neovascularization was induced in eight cynomolgus monkey eyes by occluding all the branch retinal veins with a dye-yellow (577-nm) laser. Iris angiography was done with sodium fluorescein, indocyanine green (ICG), and liposomal BPD to compare the visualization of normal and neovascular vessels by these three dyes. PDT was performed using an intravenous infusion of liposomal BPD (0.375-0.75 mg/kg), followed by irradiation with 689-nm light from a diode laser/slit-lamp delivery system using 600 mW/cm2 irradiance and 150 J/cm2 fluence. The effect of treatment was followed by iris photography and angiography, and the findings were confirmed by histopathology using light and electron microscopy. Results: Iris fluorescein angiography (FA) showed superficial tortuous and leaky new vessels. Liposomal BPD and ICG angiography of the same eye demonstrated deeper dilated and tortuous iris vessels, with minimal dye leakage. PDT of the iris with irradiation, performed within 20 minutes of the start of dye infusion (0.75 mg/kg), resulted in angiographic and histologic occlusion of iris vessels examined at 24 hours. Three to nine days after PDT, histopathologic examination showed regression of the iris neovascular membrane, with some open vessels. Conclusions: Liposomal BPD and ICG provided angiographic visualization of deeper normal and neovascular iris vessels. PDT using liposomal BPD leads to effective early closure to experimental iris neovascularization.

Original languageEnglish (US)
Pages (from-to)1242-1250
Number of pages9
JournalOphthalmology
Volume104
Issue number8
StatePublished - 1997
Externally publishedYes

Fingerprint

Photochemotherapy
Iris
Angiography
Indocyanine Green
Coloring Agents
Retinal Vein
Light
Semiconductor Lasers
Macaca fascicularis
Fluorescein Angiography
Photography
Fluorescein
Intravenous Infusions
Electron Microscopy
Lasers

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Husain, D., Miller, J. W., Kenney, A. G., Michaud, N., Flotte, T. J., & Gragoudas, E. S. (1997). Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. Ophthalmology, 104(8), 1242-1250.

Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. / Husain, D.; Miller, J. W.; Kenney, A. G.; Michaud, N.; Flotte, Thomas J; Gragoudas, E. S.

In: Ophthalmology, Vol. 104, No. 8, 1997, p. 1242-1250.

Research output: Contribution to journalArticle

Husain, D, Miller, JW, Kenney, AG, Michaud, N, Flotte, TJ & Gragoudas, ES 1997, 'Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative', Ophthalmology, vol. 104, no. 8, pp. 1242-1250.
Husain, D. ; Miller, J. W. ; Kenney, A. G. ; Michaud, N. ; Flotte, Thomas J ; Gragoudas, E. S. / Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. In: Ophthalmology. 1997 ; Vol. 104, No. 8. pp. 1242-1250.
@article{83207ea5645e4c59874d617cff224049,
title = "Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative",
abstract = "Purpose: To study the efficacy of liposomal benzoporphyrin derivative (BPD) (Verteporfin) for the angiographic visualization and photodynamic therapy (PDT) of experimental iris neovascularization. Methods: Experimental iris neovascularization was induced in eight cynomolgus monkey eyes by occluding all the branch retinal veins with a dye-yellow (577-nm) laser. Iris angiography was done with sodium fluorescein, indocyanine green (ICG), and liposomal BPD to compare the visualization of normal and neovascular vessels by these three dyes. PDT was performed using an intravenous infusion of liposomal BPD (0.375-0.75 mg/kg), followed by irradiation with 689-nm light from a diode laser/slit-lamp delivery system using 600 mW/cm2 irradiance and 150 J/cm2 fluence. The effect of treatment was followed by iris photography and angiography, and the findings were confirmed by histopathology using light and electron microscopy. Results: Iris fluorescein angiography (FA) showed superficial tortuous and leaky new vessels. Liposomal BPD and ICG angiography of the same eye demonstrated deeper dilated and tortuous iris vessels, with minimal dye leakage. PDT of the iris with irradiation, performed within 20 minutes of the start of dye infusion (0.75 mg/kg), resulted in angiographic and histologic occlusion of iris vessels examined at 24 hours. Three to nine days after PDT, histopathologic examination showed regression of the iris neovascular membrane, with some open vessels. Conclusions: Liposomal BPD and ICG provided angiographic visualization of deeper normal and neovascular iris vessels. PDT using liposomal BPD leads to effective early closure to experimental iris neovascularization.",
author = "D. Husain and Miller, {J. W.} and Kenney, {A. G.} and N. Michaud and Flotte, {Thomas J} and Gragoudas, {E. S.}",
year = "1997",
language = "English (US)",
volume = "104",
pages = "1242--1250",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative

AU - Husain, D.

AU - Miller, J. W.

AU - Kenney, A. G.

AU - Michaud, N.

AU - Flotte, Thomas J

AU - Gragoudas, E. S.

PY - 1997

Y1 - 1997

N2 - Purpose: To study the efficacy of liposomal benzoporphyrin derivative (BPD) (Verteporfin) for the angiographic visualization and photodynamic therapy (PDT) of experimental iris neovascularization. Methods: Experimental iris neovascularization was induced in eight cynomolgus monkey eyes by occluding all the branch retinal veins with a dye-yellow (577-nm) laser. Iris angiography was done with sodium fluorescein, indocyanine green (ICG), and liposomal BPD to compare the visualization of normal and neovascular vessels by these three dyes. PDT was performed using an intravenous infusion of liposomal BPD (0.375-0.75 mg/kg), followed by irradiation with 689-nm light from a diode laser/slit-lamp delivery system using 600 mW/cm2 irradiance and 150 J/cm2 fluence. The effect of treatment was followed by iris photography and angiography, and the findings were confirmed by histopathology using light and electron microscopy. Results: Iris fluorescein angiography (FA) showed superficial tortuous and leaky new vessels. Liposomal BPD and ICG angiography of the same eye demonstrated deeper dilated and tortuous iris vessels, with minimal dye leakage. PDT of the iris with irradiation, performed within 20 minutes of the start of dye infusion (0.75 mg/kg), resulted in angiographic and histologic occlusion of iris vessels examined at 24 hours. Three to nine days after PDT, histopathologic examination showed regression of the iris neovascular membrane, with some open vessels. Conclusions: Liposomal BPD and ICG provided angiographic visualization of deeper normal and neovascular iris vessels. PDT using liposomal BPD leads to effective early closure to experimental iris neovascularization.

AB - Purpose: To study the efficacy of liposomal benzoporphyrin derivative (BPD) (Verteporfin) for the angiographic visualization and photodynamic therapy (PDT) of experimental iris neovascularization. Methods: Experimental iris neovascularization was induced in eight cynomolgus monkey eyes by occluding all the branch retinal veins with a dye-yellow (577-nm) laser. Iris angiography was done with sodium fluorescein, indocyanine green (ICG), and liposomal BPD to compare the visualization of normal and neovascular vessels by these three dyes. PDT was performed using an intravenous infusion of liposomal BPD (0.375-0.75 mg/kg), followed by irradiation with 689-nm light from a diode laser/slit-lamp delivery system using 600 mW/cm2 irradiance and 150 J/cm2 fluence. The effect of treatment was followed by iris photography and angiography, and the findings were confirmed by histopathology using light and electron microscopy. Results: Iris fluorescein angiography (FA) showed superficial tortuous and leaky new vessels. Liposomal BPD and ICG angiography of the same eye demonstrated deeper dilated and tortuous iris vessels, with minimal dye leakage. PDT of the iris with irradiation, performed within 20 minutes of the start of dye infusion (0.75 mg/kg), resulted in angiographic and histologic occlusion of iris vessels examined at 24 hours. Three to nine days after PDT, histopathologic examination showed regression of the iris neovascular membrane, with some open vessels. Conclusions: Liposomal BPD and ICG provided angiographic visualization of deeper normal and neovascular iris vessels. PDT using liposomal BPD leads to effective early closure to experimental iris neovascularization.

UR - http://www.scopus.com/inward/record.url?scp=0031472966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031472966&partnerID=8YFLogxK

M3 - Article

C2 - 9261310

AN - SCOPUS:0031472966

VL - 104

SP - 1242

EP - 1250

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 8

ER -